financetom
Business
financetom
/
Business
/
Shell Wins Appeal Against Landmark Climate Ruling, Dodging Major Emission Cut Mandate
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Shell Wins Appeal Against Landmark Climate Ruling, Dodging Major Emission Cut Mandate
Nov 12, 2024 8:24 PM

Shell PLC ( SHEL ) shares are trading lower on Tuesday. The company won an appeal against a landmark climate ruling at a Dutch court in the case brought against by Milieudefensie, other NGOs, and private individuals.

The court overturned the mandate requiring the company to significantly cut its emissions.

Notably, in 2021, The Hague’s District Court ruled that Shell must cut its reported global net carbon emissions across Scopes 1, 2, and 3 by 45% by 2030, relative to 2019 levels.

This required a “results-based” reduction for Scope 1 and a “significant best efforts” reduction for Scopes 2 and 3. Shell’s appeal did not pause this ruling.

Chief Executive Officer Wael Sawan said, “Our target to become a net-zero emissions energy business by 2050 remains at the heart of Shell’s strategy and is transforming our business. This includes continuing our work to halve emissions from our operations by 2030.”

Shell has previously noted that a court ruling alone wouldn’t curb overall demand for products like petrol, diesel, or natural gas, as customers would simply shift to other suppliers.

Shell believes real progress towards net-zero emissions requires coordinated government policies, investments, and cross-sector action.

As disclosed in March 2024, Shell reaffirmed its ambition to reduce customer emissions from the use of its oil products by 15-20% by 2030 compared with 2021 and against its previous target of 20%.

Also earlier, the company reiterated its targeted investment of $10 billion-$15 billion in 2023-2025 in low-carbon energy solutions.

Notably, in 2023, Shell invested $5.6 billion in low-carbon solutions, accounting for over 23% of the total capital spending.

By the end of 2023, Shell had accomplished over 60% of its goal to reduce Scope 1 and 2 emissions from its operations by 50% by 2030, relative to 2016 levels.

Moreover, in 2023, Shell invested $5.6 billion in low-carbon solutions, accounting for over 23% of the total capital spending.

Also Read: Shell Reports Strong Q3: Analysts Highlight Robust Buybacks Amid Market Challenges

Investors can gain exposure to Shell via First Trust Exchange-Traded Fund IV FT Energy Income Partners Strategy ETF  and Xtrackers RREEF Global Natural Resources ETF ( NRES ) .

Price Action: SHEL shares are down 2.76% at $65.00 at the last check Tuesday.

Image by siam.pukkato via Shutterstock

Read Next:

Elon Musk Announced Tesla’s Berlin Gigafactory 5 Years Ago Today: Here’s How EV Giant’s Mega Factory Has Evolved

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Members Can Get WeightWatchers Prescriptions Quicker Thanks To Amazon Pharmacy Partnership
Members Can Get WeightWatchers Prescriptions Quicker Thanks To Amazon Pharmacy Partnership
Oct 20, 2025
WW International, Inc. ( WW ) , known as WeightWatchers, stock surged Monday after announcing a partnership with Amazon.com, Inc.’s  Amazon Pharmacy to make weight management medications easier to access for its clinic members. The collaboration offers real-time prescription availability, automatic savings, and home delivery options for patients using weight-loss treatments such as GLP-1 medications. The initiative comes amid soaring nationwide demand...
Merck Says Keytruda Shows Long-Term Survival Benefit in Non-Small Cell Lung Cancer Patients
Merck Says Keytruda Shows Long-Term Survival Benefit in Non-Small Cell Lung Cancer Patients
Oct 20, 2025
09:37 AM EDT, 10/20/2025 (MT Newswires) -- Merck ( MRK ) said Monday that new long-term data from a phase 3 trial of its cancer drug Keytruda showed sustained survival benefits in patients with earlier or advanced stages of non-small cell lung cancer. The drugmaker said that five-year follow-up data on Keytruda continued to show a clinically meaningful improvement in...
BRIEF-UK's CMA On Merger Update Of Global Payments / Worldpay
BRIEF-UK's CMA On Merger Update Of Global Payments / Worldpay
Oct 20, 2025
Oct 20 (Reuters) - COMPETITION AND MKTS : * COMPETITION AND MKTS - MERGER UPDATE : GLOBAL PAYMENTS ( GPN ) / WORLDPAY * UK'S CMA SAYS NOT TO REFER GLOBAL PAYMENTS / WORLDPAY MERGER TO A PHASE 2 INVESTIGATION Source text: ;)) ...
IBM Set for Another 'Solid' Quarter Driven by AI Demand, Wedbush Says
IBM Set for Another 'Solid' Quarter Driven by AI Demand, Wedbush Says
Oct 20, 2025
09:40 AM EDT, 10/20/2025 (MT Newswires) -- International Business Machines ( IBM ) is expected to record another solid quarter and top Wall Street estimates due to artificial intelligence demand for its software offerings, Wedbush analysts said in a Sunday note. The company is scheduled to report its Q3 financial results on Wednesday. Analysts polled by FactSet expect the company...
Copyright 2023-2026 - www.financetom.com All Rights Reserved